Evaluation of MCL-1 as a prognostic factor in canine mammary gland tumors
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0306398 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Jaeho Cho und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Clinical Sciences, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, …. Hauptthemen laut MEDLINE: Myeloid Cell Leukemia Sequence 1 Protein, Mammary Neoplasms, Animal, Dog Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BK21 program, College of Veterinary Medicine, Seoul National University.
Abstract (Originalsprache)
Myeloid cell leukemia-1 (MCL-1), which belongs to the anti-apoptotic B cell lymphoma-2 family protein, is overexpressed in various cancers and is associated with cell immortality, malignant transformation, chemoresistance, and poor prognosis in humans. However, the significance of MCL-1 in canine mammary gland tumors (MGTs) remains unknown. This study aimed to examine MCL-1 expression in normal canine mammary glands and tumors and to assess its correlation with clinical and histologic variables. In total, 111 samples were examined, including 12 normal mammary gland tissues, 51 benign MGTs, and 48 malignant MGTs. Immunohistochemistry revealed that 53% of benign tumors and 75% of malignant tumors exhibited high MCL-1 expression, whereas only 8% of normal mammary glands exhibited high MCL-1 expression. High MCL-1 expression correlated with tumor malignancy (p < 0.001), large tumor size (> 3 cm) (p = 0.005), high Ki-67 expression (p = 0.046), and metastasis (p = 0.027). Survival curve analysis of dogs with malignant MGTs demonstrated a significant association between high MCL-1 expression and shorter median overall survival (p = 0.027) and progression-free survival (p = 0.014). Our study identified MCL-1 as a prognostic factor and potential therapeutic target in canine MGTs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Clinical Sciences, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, Republic of Korea.
- Department of Veterinary Surgery, College of Veterinary Medicine, Chungbuk National University, Cheongju, Republic of Korea.
ORCID-Profile: Sungin Lee, Wan Hee Kim
Förderung
- BK21 program, College of Veterinary Medicine, Seoul National University
Zitieren
APA
Cho, J., Chung, H., Lee, S., & Kim, W. H. (2024). Evaluation of MCL-1 as a prognostic factor in canine mammary gland tumors. PLOS ONE. https://doi.org/10.1371/journal.pone.0306398
Vancouver
Cho J, Chung H, Lee S, Kim WH. Evaluation of MCL-1 as a prognostic factor in canine mammary gland tumors. PLOS ONE. 2024. doi:10.1371/journal.pone.0306398
BibTeX
@article{Cho2024,
author = {Cho, Jaeho and Chung, Heaji and Lee, Sungin and Kim, Wan Hee},
title = {Evaluation of MCL-1 as a prognostic factor in canine mammary gland tumors},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0306398}
}
EUVIMED